Collectively, these data support the notion that phosphorylation of PRMT5 at S15 can augment NF-ĸB signaling via regulation of p65 transactivation potential and a subset of NF-κB target genes whose functions are pro-inflammatory and cancer-related in nature. The gene discussed is PRMT5; the disease is cancer.